| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $0 ) |
| 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 000 | 5 | 11/4/2024 | NON-COMPETING CONTINUATION | $0 |
| 2025 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 001 | 5 | 11/7/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $387,877 ) |
| 2024 | 2024 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 001 | 5 | 1/26/2024 | NON-COMPETING CONTINUATION | $387,877 |
| 2024 | 2023 | THE NEMOURS FOUNDATION | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 000 | 4 | 1/26/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $393,477 ) |
| 2023 | 2023 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 000 | 4 | 1/23/2023 | NON-COMPETING CONTINUATION | $393,477 |
|
| Issue Date FY: 2022 ( Subtotal = $399,656 ) |
| 2022 | 2022 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 000 | 3 | 12/22/2021 | NON-COMPETING CONTINUATION | $399,656 |
|
| Issue Date FY: 2021 ( Subtotal = $400,000 ) |
| 2021 | 2021 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 000 | 2 | 1/28/2021 | NON-COMPETING CONTINUATION | $400,000 |
|
| Issue Date FY: 2020 ( Subtotal = $238,439 ) |
| 2020 | 2020 | NEMOURS FOUNDATION, THE | 1600 ROCKLAND RD | WILMINGTON | DE | 19803 | NEW CASTLE | USA | Research on Healthcare Costs, Quality and Outcomes | 000 | 1 | 3/12/2020 | NEW | $238,439 |
|
|